Jove
Visualize
Contact Us

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A primer for cancer research programs on defining and evaluating the catchment area and evaluating minority clinical trials recruitment.

Advances in cancer research·2020
Same author

Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials.

Cancer·2020
Same author

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey.

Contemporary clinical trials communications·2018
Same author

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.

Cancer prevention research (Philadelphia, Pa.)·2018
Same author

Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials.

Journal of cancer education : the official journal of the American Association for Cancer Education·2017
Same author

Missing documentation in breast cancer survivors: genitourinary syndrome of menopause.

Menopause (New York, N.Y.)·2017
Same journal

Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings.

Current oncology reports·2026
Same journal

Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.

Current oncology reports·2026
Same journal

Anti-PD-1 Combinations: Triplets and Beyond.

Current oncology reports·2026
Same journal

Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.

Current oncology reports·2026
Same journal

Clusterin in Head and Neck Squamous Cell Carcinoma: Diagnostic, Prognostic, and Therapeutic Implications.

Current oncology reports·2026
Same journal

Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies.

Current oncology reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Prostate cancer screening.

Elise D Cook1, Ana C Nelson

  • 1The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Street, Cancer Prevention Center, Unit 1360, Houston, TX 77030, USA. edcook@mdanderson.org

Current Oncology Reports
|October 29, 2010
PubMed
Summary
This summary is machine-generated.

Routine prostate cancer screening using the prostate-specific antigen (PSA) test offers benefits in lowering mortality but raises concerns about over-diagnosis and over-treatment. Recent trials and guidelines inform clinical practice regarding these risks and benefits.

More Related Videos

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Prostate cancer is a leading cause of death in American men.
  • Prostate-specific antigen (PSA) testing has increased early diagnoses since the 1990s.
  • Current evidence on the benefits and risks of routine PSA screening is conflicting.

Purpose of the Study:

  • To review recent prostate cancer screening trials.
  • To examine current screening guidelines from major organizations.
  • To discuss clinical implications of prostate cancer screening.

Main Methods:

  • Analysis of recent prostate cancer screening trials.
  • Review of National Comprehensive Cancer Network (NCCN) guidelines.
  • Review of American Cancer Society (ACS) screening guidelines.

Main Results:

  • Conflicting evidence exists regarding the net benefit of PSA screening.
  • Concerns persist about over-diagnosis and subsequent over-treatment.
  • Guidelines from NCCN and ACS provide recommendations for screening.

Conclusions:

  • Clinical practice must balance the benefits of early detection with the risks of over-treatment.
  • Recent trial data and updated guidelines inform decision-making for prostate cancer screening.
  • Further research may clarify optimal screening strategies.